Places available


Deadline for application



What we need 

- Master title (or equivalent) in Biomedical Sciences.

- Master title (or equivalent) in Business (MBA for example) from top school preferred.

- Highly motivated and organized candidates.

- Previous experience in valorization and technology transfer activities will be valued.

- Fluent in English and other languages valued.

Skills specifications:

  • Strong leadership skills - able to make decisions, challenge those within the business and take a no-fuss approach to overcoming challenges.
  • Strategic mindset.
  • Professional business acumen.
  • Outstanding problem-solving skills.
  • Excellent ability to lead and manage.
  • Continually drive effective results.
  • Communicate effectively at all levels and fluency in English.
  • Experience leading fundraising rounds.


Main Responsibilities

Under the supervision of Manel Esteller, the Director of IJC, and in collaboration with Innovation Unit, the Intrapreneur would lead the creation of the new spinoff.

Among other functions will perform:

  • Develop and implement business plan:

o   Market analysis.

o   Strategy analysis.

o   Gap analysis.

o   Commercial validation.

o   Customer engagement.

  • Secure Funding for the company
  • Select and manage providers to define legal and regulatory framework and obtain needed approvals
  • Select the teamwork
  • Establish a location for the company
  • Develop and implement Marketing Strategy


What we offer

- A 2-year position is available to start on February 15th, 2022.

- Incorporation in a multinational and highly collaborative team.

- An exciting and innovative project of creating a new company.

- Working in the mixed basic, clinical research and innovation environment of the Josep Carreras Leukaemia Research Institute.

- Contract details will be negotiated and consider the track record of the candidate.

- Preferential start date: February 15th.

- Job location in IJC Badalona.

- Full time contract.

Additional Information

The Josep Carreras Leukemia Research Institute (IJC) is a nonprofit research institute based in Barcelona and dedicated to advancing our understanding about leukemia and related disorders, in partnership with the University of Barcelona and University Autònoma of Barcelona. The IJC has laboratories in three clinical campuses: i) Clinic Hospital, ii) Sant Pau Hospital and iii) Germans Trias i Pujol Hospital. IJC serves as a collaborative hub for basic investigators and physicians to work together on fundamental biological and clinical aspects of leukemia. The IJC offers an excellent work environment built around a multi-disciplinary fusion of ideas and state-of-the-art facilities.

For further information, please, visit our webpage: and the Josep Carreras nonprofit organization:

The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.

The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.

This EC initiative aims to promote training, professional development, and mobility for all European scientists.  The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research and firmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.

IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.


Research Description

Intrapreneurship is acting like an entrepreneur within an established entity. It’s creating a new business or venture within an organization. Sometimes that business becomes a new section, or department, or even a subsidiary spinoff.

“You need to think about how big the market is, how many resources do they need to create something, what could the payoff be. Many of the same criteria that we would use to evaluate a new venture by an entrepreneur is really the same.”, MIT Sloan professor Michael Cusumano, an expert in strategy, product development, and entrepreneurship.

IJC is interested on creating an spin-off based on service platform and focused on developing experimental model for broad range of mutation carrier patients, associated to different hereditary diseases such as hereditary cancers and rare diseases.

Intrapreneur would develop the NewCo project inside IJC for a maximum of 2 years and eventually become the CEO of the new independent spin-off, if this happens to be feasible (legal, regulatory, technical, economical parameters and IJC Patronage’s approval).

Place of presentation of the candidacies

How to apply

To apply for this opportunity, please send your resume and a cover letter and (incl. the contact details of two referees) including the reference: IJP_ME_127.


Deadline for Applications

Please submit your application by February 10th, 2022

Enlaces relacionados